Cardlytics, Inc. (NASDAQ:CDLX) Director John V. Balen Buys 1,000 Shares

Cardlytics, Inc. (NASDAQ:CDLXGet Rating) Director John V. Balen purchased 1,000 shares of the company’s stock in a transaction dated Monday, May 9th. The shares were acquired at an average price of $28.35 per share, with a total value of $28,350.00. Following the transaction, the director now owns 33,097 shares in the company, valued at approximately $938,299.95. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

CDLX opened at $29.42 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.29 and a quick ratio of 1.10. The stock’s 50 day simple moving average is $47.56 and its 200 day simple moving average is $61.67. The firm has a market cap of $1.00 billion, a price-to-earnings ratio of -13.13 and a beta of 2.47. Cardlytics, Inc. has a 1 year low of $27.94 and a 1 year high of $134.91.

Cardlytics (NASDAQ:CDLXGet Rating) last issued its earnings results on Monday, May 2nd. The company reported ($0.75) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.11) by $0.36. Cardlytics had a negative net margin of 25.06% and a negative return on equity of 13.81%. The firm had revenue of $67.93 million for the quarter, compared to analysts’ expectations of $65.84 million. During the same quarter last year, the business earned ($0.59) earnings per share. As a group, sell-side analysts anticipate that Cardlytics, Inc. will post -3.24 EPS for the current year.

Institutional investors have recently made changes to their positions in the business. CAS Investment Partners LLC boosted its holdings in shares of Cardlytics by 0.7% during the fourth quarter. CAS Investment Partners LLC now owns 5,186,466 shares of the company’s stock worth $342,774,000 after purchasing an additional 36,875 shares during the period. FMR LLC lifted its holdings in Cardlytics by 2.3% in the 1st quarter. FMR LLC now owns 3,284,572 shares of the company’s stock worth $54,327,000 after buying an additional 72,847 shares during the period. KPS Global Asset Management UK Ltd grew its position in shares of Cardlytics by 5.9% in the 4th quarter. KPS Global Asset Management UK Ltd now owns 1,246,830 shares of the company’s stock worth $82,403,000 after buying an additional 70,000 shares during the last quarter. Baillie Gifford & Co. increased its stake in shares of Cardlytics by 15.1% during the first quarter. Baillie Gifford & Co. now owns 1,056,208 shares of the company’s stock valued at $58,071,000 after buying an additional 138,332 shares during the period. Finally, Morgan Stanley raised its holdings in shares of Cardlytics by 24.1% during the third quarter. Morgan Stanley now owns 934,559 shares of the company’s stock valued at $78,446,000 after acquiring an additional 181,266 shares in the last quarter. 97.57% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts have recently commented on CDLX shares. Needham & Company LLC decreased their price target on shares of Cardlytics from $85.00 to $60.00 and set a “buy” rating on the stock in a report on Tuesday, May 3rd. Zacks Investment Research upgraded Cardlytics from a “hold” rating to a “buy” rating and set a $43.00 price target on the stock in a research report on Thursday, May 5th. Craig Hallum decreased their price objective on Cardlytics from $70.00 to $50.00 in a report on Tuesday, May 3rd. Finally, Wells Fargo & Company assumed coverage on shares of Cardlytics in a research note on Tuesday, April 5th. They issued an “overweight” rating and a $72.00 price objective for the company. Four investment analysts have rated the stock with a buy rating, According to data from, the company presently has an average rating of “Buy” and a consensus target price of $56.25.

Cardlytics Company Profile (Get Rating)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Read More

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with's FREE daily email newsletter.